Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Recruiting

Phase 1

REGN20934Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Sponsor:

Regeneron Pharmaceuticals

Code:

NCT07594093

Conditions

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

REGN20934

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-20. This information was provided to ClinicalTrials.gov by Regeneron Pharmaceuticals on 2026-07-07.